United States · Platforms & data · TipRanks

Tempus AI expands collaboration with Bristol Myers

Published by TipRanks · United States 16 h ago

Tempus AI (TEM) announced a multi-year agreement with Bristol Myers Squibb (BMY), under which BMS will license multimodal oncology data from Tempus through 2031 to ...

Read the full article on TipRanks Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.tipranks.com)

Also worth reading

The Motley Fool

Not Nvidia. Not Micron. This Little-Known Chip Stock Is the AI Boom's Best-Kept Secret.

MarketBeat

Tractor Supply's Q3 Beat Plants the Seeds for a Stock Rebound

Seeking Alpha

Celestica Q3 2026 earnings preview: Analysts expect wide Y/Y growth

MarketWatch

We have a $300,000 mortgage with a 2.75% interest rate. I want to pay it off. My husband says I’m crazy. Who’s right?

Investing.com

Earnings call transcript: Ameris Bancorp tops Q3 2026 EPS forecast

Benzinga